NEW YORK ( TheStreet) -- Shares of Insmed (Nasdaq: INSM) have taken a tremendous swing upward. The stock is trading at $4.46 as of 2:55 p.m. ET, 20.5% above Wednesday's closing price of $3.70. Volume is at 160,143, 0.5 times the daily average of 292,200.

Insmed has a market cap of $94.9 million and is part of the health care sector and drugs industry. Shares are down 41.3% year to date as of the close of trading on Wednesday.

Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.

TheStreet Ratings rates Insmed as a hold. Among the primary strengths of the company is its solid financial position based on a variety of debt and liquidity measures that we have evaluated. At the same time, however, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. You can view the full Insmed Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.
null

If you liked this article you might like

North Korea Gives Wall Street Rude Awakening After Labor Day Break

Dow Tanks, Fear Gauge Spikes as United Tech Slumps, North Korea Rattles Nerves

North Korea Threat Roars Back Into Focus and Wall Street Retreats

Stock Futures Decline Amid Rising North Korea Tensions

Health Sector Down As Report of Industry Price Collusion Surfaces